Dudediligence.

Ocugen, Inc

OCGNNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Price
FilingsNewest: 8-K, Shareholder voteOct 5 →Insiders1 insider bought $25,830 in 1 open-market buy. No sales.→HoldersBlackRock 8.0%State Street 6.3%Vanguard 4.2%→Financing →PeersClosest companies: VRDN, SEPN, WHWK→

From the filings

Figures

Revenue
$4.6Mlast 12 months
Net income
−$82.0Mlast 12 months
Operating cash flow
−$59.4Mlast 12 months
Cash and equivalents
$100.1Mat the last balance sheet
Total debt
$1.7Mat the last balance sheet
Shares outstanding
339.0M shareson issue
Every year and quarter →